Product category:
Contract research
News Release from: STFC Daresbury Laboratory | Subject: Synchrotron
Edited by the Laboratorytalk Editorial
Team on 01 July 2003
X-ray expertise highlights protein
deviants
The effect of gene mutations on the development of the inherited or familial form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease
In a groundbreaking study recently published in Nature Structural Biology, scientists have uncovered the effect of gene mutations on the development of the inherited or familial form of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease Subtle but deadly differences in the shape of some, but not all, superoxide dismutase proteins lead to the formation of abnormal aggregates which, it is believed, in some way kill off the motor neurons, leaving an affected individual paralysed
This article was originally published on Laboratorytalk on 8 Mar 2002 at 8.00am (UK)
Related stories
Synchrotron sheds light on cancer diagnosis
CLRC Daresbury's Synchrotron Radiation Department has provided details of its groundbreaking use of scattered x-rays for breast cancer screening, reducing the need for biopsies
Protein screening at top speed
Use of synchrotron facilities and years of experience allows the rapid determination of protein crystal structure, reducing the initial screening operation from months to weeks
The new evidence should now make possible the future development of compounds which will cling to the mutant proteins to prevent the clumping effect.
The research team at Daresbury Laboratory led by Professor Samar Hasnain collaborated with teams at Universities of Texas, California, and Massachusetts.
High resolution pictures of the mutant proteins were obtained via three-dimensional x-ray crystallography, using the powerful X-ray synchrotron radiation facilities at Daresbury and New York.
"This major breakthrough in discovering the molecular basis of this motor neuron disease has been made possible by the establishment of an international consortium, bringing together enzymologists, clinicians and structural biologists," said Samar Hasnain.
"The synchrotron source at Daresbury has allowed us to investigate the human enzyme and mutants causing the disease, and their structures have provided some important clues for the disease process." ALS affects about 1 in 1000 people, 10% of whom are familial cases and the remaining 90% sporadic, with no apparent link to inheritance.
It is hoped that by understanding the inherited form of ALS scientists may also learn more about the sporadic cases.
Lucie Bruijn, science director and vice president of the ALS Association, said: "The presence of aggregated proteins in neurodegenerative diseases such as Alzheimer's, Hungtington's and ALS is an emerging common theme.
These findings may lead to an understanding of how to disrupt aggregate formation and should these be integral to the disease mechanism, may lead to potential therapeutic approaches.".
• STFC Daresbury Laboratory: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
